Epilepsy Seizures Drop 50% in Cannabidiol Study

Monday, Nov 24, 2014

VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) -- A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy.

Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment.

Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date.

"Most CBD's taste awful," stated Lexaria CEO and Chairman Chris Bunka in an exclusive interview with Financial Press. "Marian Washington and Michelle Reillo – the two principals at PoViva – have developed patent-pending technology to bind CBD to a lipid. As well as enabling the body to process the CBDs more efficiently, this technology makes it taste much better."

Trending Now